Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Ferris

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Alzheimer Disease and Associated Disorders|December 28, 1999
Cognitive outcome measuresS H Ferris
Clinical Therapeutics|June 9, 2001
Switching previous therapies for Alzheimer's disease to galantamineS H Ferris
The Psychiatric Clinics of North America|June 1, 1991
Scales for the assessment of Alzheimer's diseaseA Kluger, S H Ferris
Science (New York, N.Y.)|October 15, 1971
Interocular apparent movement in depth: a motion preference effectS H Ferris, N Pastore
Alzheimer Disease and Associated Disorders|January 1, 1997
Assessing cognition in Alzheimer disease researchS H Ferris, A Kluger
Hospital & Community Psychiatry|February 1, 1982
Diagnosis and assessment of the older patientB Reisberg, S H Ferris
Alzheimer Disease and Associated Disorders|January 1, 1997
Behavioral outcomes in clinical trials for Alzheimer diseaseS H Ferris, J A Mackell
Neurology|July 1, 1991
Mild cognitive impairment in the elderly: predictors of dementiaC Flicker, S H Ferris, B Reisberg
Psychopharmacology|January 1, 1992
Hypersensitivity to scopolamine in the elderlyC Flicker, S H Ferris, M Serby
Psychopharmacology|January 1, 1990
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speedC Flicker, M Serby, S H Ferris
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Alzheimer Disease and Associated Disorders|December 28, 1999
Cognitive outcome measuresS H Ferris
Clinical Therapeutics|June 9, 2001
Switching previous therapies for Alzheimer's disease to galantamineS H Ferris
The Psychiatric Clinics of North America|June 1, 1991
Scales for the assessment of Alzheimer's diseaseA Kluger, S H Ferris
Science (New York, N.Y.)|October 15, 1971
Interocular apparent movement in depth: a motion preference effectS H Ferris, N Pastore
Alzheimer Disease and Associated Disorders|January 1, 1997
Assessing cognition in Alzheimer disease researchS H Ferris, A Kluger
Hospital & Community Psychiatry|February 1, 1982
Diagnosis and assessment of the older patientB Reisberg, S H Ferris
Alzheimer Disease and Associated Disorders|January 1, 1997
Behavioral outcomes in clinical trials for Alzheimer diseaseS H Ferris, J A Mackell
Neurology|July 1, 1991
Mild cognitive impairment in the elderly: predictors of dementiaC Flicker, S H Ferris, B Reisberg
Psychopharmacology|January 1, 1992
Hypersensitivity to scopolamine in the elderlyC Flicker, S H Ferris, M Serby
Psychopharmacology|January 1, 1990
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speedC Flicker, M Serby, S H Ferris
Pageof 9